Presenter Dr Joan Gluch--Bridging the Gaps: Providing health-related service for underserved populations while training future health professionals, as presented at The Strengthening Ohio’s Safety Net Roundtable April 29, 2011. For more info, visit http://www.healthpathohio.org/
Presenter Dr Joan Gluch--Bridging the Gaps: Providing health-related service for underserved populations while training future health professionals, as presented at The Strengthening Ohio’s Safety Net Roundtable April 29, 2011. For more info, visit http://www.healthpathohio.org/
HIV+ logbook tracks HIV + mother-baby pairs from pregnancy to 18 months post-partum
HIV- logbook tracks HIV- women through pregnancy for retesting at three months
This presentation illustrates the advantage of transitioning from RED to REC to strengthen immunization services and health systems. Linking immunizations with communities motivates others to use immunization and other PHC services, arrange a clean outreach site, transport vaccines and health workers (particularly for outreach sessions), etc.
Transitioning from reach every district to reach every communityJSI
The presentation describes the expansion for routine immunization from district level to community level in Africa. Reaching remote communities is important to bring immunization to all children.
Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...Office of HIV Planning
Mari Ross-Russell (Office of HIV Planning) and Matthew McClain (Public Health Policy & Planning Consultant) presented these slides to the PrEP Workgroup of the Philadelphia EMA HIV Integrated Planning Council on January 16, 2019.
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
Transitioning from reaching every district to reaching every communityJSI
This presentation focuses on learning acquired from the last 2-3 year effort in 8 districts across both Uganda and Ethiopia and REC-QI potential to add to the arsenal of RI strengthening tools. REC is now the number one approach to reaching hard-to-reach health facilities. Adding Quality improvement to RED/REC will combine the “what” (RED/REC) and “how” (QI) factors to strengthening for sustainable improvement in coverage and brings together all EPI stakeholders. In addition, by working at both national and lower level, REC-QI encourages peer learning and incorporation of innovations into national policies, guidelines, and protocols.
An exploration of Social media through the eyes of a Chief Medical Officer and clinicians. How can they effectively leverage resources in healthcare marketing and social media. Learn about the roles, responsibilities and activities of these clinical professionals and how they can be effectively used to extend marketing reach and build market thought leadership programs
How Consumer Participation can transform and organisationUniting ReGen
Delivered by ReGen's Consumer Participation Facilitator Regina Brindle at the 2014 Australian Winter School. For other presentations from the event, see the conference website: http://winterschool.info/speaker-presentations/
HIV+ logbook tracks HIV + mother-baby pairs from pregnancy to 18 months post-partum
HIV- logbook tracks HIV- women through pregnancy for retesting at three months
This presentation illustrates the advantage of transitioning from RED to REC to strengthen immunization services and health systems. Linking immunizations with communities motivates others to use immunization and other PHC services, arrange a clean outreach site, transport vaccines and health workers (particularly for outreach sessions), etc.
Transitioning from reach every district to reach every communityJSI
The presentation describes the expansion for routine immunization from district level to community level in Africa. Reaching remote communities is important to bring immunization to all children.
Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...Office of HIV Planning
Mari Ross-Russell (Office of HIV Planning) and Matthew McClain (Public Health Policy & Planning Consultant) presented these slides to the PrEP Workgroup of the Philadelphia EMA HIV Integrated Planning Council on January 16, 2019.
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
Transitioning from reaching every district to reaching every communityJSI
This presentation focuses on learning acquired from the last 2-3 year effort in 8 districts across both Uganda and Ethiopia and REC-QI potential to add to the arsenal of RI strengthening tools. REC is now the number one approach to reaching hard-to-reach health facilities. Adding Quality improvement to RED/REC will combine the “what” (RED/REC) and “how” (QI) factors to strengthening for sustainable improvement in coverage and brings together all EPI stakeholders. In addition, by working at both national and lower level, REC-QI encourages peer learning and incorporation of innovations into national policies, guidelines, and protocols.
An exploration of Social media through the eyes of a Chief Medical Officer and clinicians. How can they effectively leverage resources in healthcare marketing and social media. Learn about the roles, responsibilities and activities of these clinical professionals and how they can be effectively used to extend marketing reach and build market thought leadership programs
How Consumer Participation can transform and organisationUniting ReGen
Delivered by ReGen's Consumer Participation Facilitator Regina Brindle at the 2014 Australian Winter School. For other presentations from the event, see the conference website: http://winterschool.info/speaker-presentations/
Realising the Value Stakeholder Event -Workshop: How does the system support Nesta
Workshop D - How does the system support communities/individuals and how could it do it better?
The levers and drivers that national bodies put in place and how these are used locally have a significant impact on working in partnership with communities and patients. These levers and drivers include regulation, targets, outcomes measures, financial flows, annual contracting cycles, clinical standards, workforce training and revalidation etc.
This workshop will draw upon your experience and evidence to address two questions:
How these levers and drivers get in the way of working in partnership with patients and communities?
What is the best blend of approaches to support commissioners and providers locally to harness the energy of patients and communities
A presentation outlining Wessex AHSN's proposed approach to spreading and adopting best practice and innovation in health and care across the Wessex region. This presentation was delivered on 19 November at the AHSN's Innovation Forum, held in Chilworth.
Using the IAP2 framework is a great place to start when thinking about partnering with consumers. This slide-deck touches on consumer participation, accreditation standards and case studies in participation.
Meaningful and active collaboration with public and patient partners in planning, conducting and disseminating rapid reviews helps ensure that their perspectives are considered in research priorities and in shaping the evidence and care they receive.
Join us for an interactive session to learn about meaningfully engaging public partners in rapid reviews. We will present a spectrum of strategies to involve public partners and share lessons learned to optimize these opportunities. Public and patient partners will also present and share their perspectives and experiences.
New Models of Care Strategy for Vanguards and PioneersHIMSS UK
Helen Arthur, Technology Vanguards Lead, NHS England
Mark Gollege, Local Government Association
Indi Singh, Interoperability Lead, NHS England
Andy Evans, Sherwood Forest Hospitals
This presentation on using a systems approach to improve understandings of peer-based health promotion programs was given by Dr Graham Brown, Australian Research Centre for Sex, health and Society (ARCSHS), at the AFAO Members Forum - May 2015.
Similar to Jennifer Neff / Leeann Monk Ozgul, Co Founders and Co CEOs Elemental (20)
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
4. Introduction to Elemental
Scaling and evidencing the impact
of social prescribing
1. Access for all that need it
1. Evidence the impact that the
VCSE plays in delivering
community health and wellbeing
8. This session
1. Developing/ scaling your
model
2. Increasing access to your
programmes
3. Supporting your link workers
4. Building the capacity of your
community network
5. Measuring success
11. Primary Care Networks
All GP practices are expected to come
together in geographical networks
covering populations of approximately
30–50,000 patients by June 2019
NHS England has significant ambitions
for primary care networks, with the
expectation that they will be a key
vehicle for delivering many of the
commitments in the long-term plan and
providing a wider range of services to
patients.
12. Drivers and Challenges
HEALTH, HOUSING & SOCIAL CARE
PROFESSIONALS
• Want to provide social prescribing
• No time to research activities in the community
• No quality assurance on suppliers
• No ability to track & monitor patient progress
after referral
PATIENTS/RESIDENTS/CITIZENS
• Want to receive social prescriptions to reduce
their health risks
• Want to know more about health & wellbeing
activities in community
• Need 1-1 support to keep motivated
HEALTH, HOUSING & SOCIAL CARE
COMMISSIONERS
• Need analytics from commissioned programmes
to prove value for money
• Need to track outcomes to justify expenditure
COMMUNITY & VOLUNTARY
PROVIDERS
• Need to track project outcomes to prove value
for money to commissioners
• Need to track individual patient health risk to
report back to their funders
14. ● Established who the providers are
● Determine the offering
● Identify the gaps in partnerships/ services/ access
● Connect it back to an area’s strategic goals
MAPPING/
UNCOVERING THE
ASSETS IN A PLACE
● Deliver ways to engage stakeholders through
workshops/ webinars/ interviews
● Facilitate the discussions
● Co produce the vision with the partners
CO DEVELOP THE VISION
● Nearly 500 Link Workers trained by Elemental
team on digital social prescribing
● Nearly 2000 health and social care professionals
trained in digital referral making (of which 1488 are
GPs)
PROVIDE TRAINING
● Work with partners from a neighbourhood, a
whole STP level and to bigger regions
● Create the learning and sharing environments to
ensure the widespread adoption
CONNECT A REGION
Co creating the vision
15. Someone who can make referrals for a resident to take part in the
project
REFERRAL AGENTS
GP/ Nurse/ Housing Officer/ Social
Worker
Someone who has been assigned the responsibility to receive
referrals from the referral agents
REFERRAL HANDLERS
Social Prescribing Link Worker
An organisation selected to be part in the social prescribing
programme of the select list of providers for the project
PROVIDERS
Internal Provider/ External Providers
Anyone that meets the project’s inclusion criteria-
Example: Debt, rent arrears, mild depression, social isolation
etc
PATIENT/TENANT/
CITIZEN
Roles and responsibilities
16. Measuring the impact
● The impact on the person
● The impact on the community
● The impact of the system
20. 2. BE REFERRED BY SOMEONE GIVEN REFERRAL MAKING
RIGHTS USING ELEMENTAL URL
Be referred using the Elemental URL
21. Browse Self Refer Self Serve
Customise Self Refer with your
branding and programme
information so you have the
workflow that suits you.
1. ‘Self Refer’ option to a Link
Worker for those who need
Link Worker Supporter
2. ‘Browse’ option for those who
are more motivated to see
what’s available
Self refer option
31. Measuring the impact
● The impact on the person
● The impact on the community
● The impact of the system
32. Impact on the patient
• Activation Levels (PAM) monthly
• Mental Wellbeing (SWEBWEB)
• Personal General Wellbeing (ONS4)
Impact on the community
(VCSE Sector)
• Number of referrals received
• Most common reasons for referral
Impact on the Health
& Care System
• GP Appointment
• A&E Appointments
• Prescribed medication
Linked Datasets – Proving the case for Social Prescribing
33. E-Learning Provision
Providing users with an understanding of what Social Prescribing is and how to use / implement it.
Example Modules: May Include;
• How to imbed social prescribing within your PCN
• How to recruit/induct your link worker
• How to quality assure the programme
• The operational governance required
• The value of the VCSE Sector
• Resource bank
• How to effectively manage the change
• Change within the GP practice
• Clinical governance framework
• Data/GDPR implications
• How to use the Data dashboards
• Input strategy
• Extraction
• Data dashboards
34. Timescales
Stage 1
● Programme launched at Unco - 16th October 2019
● Expressions of interest opens for sites (3 sites across England will be chosen) – 29th
November 2019
● 3 trailblazer sites identified and promoted – 9th December 2019
● Co creation programme design with trailblazer sites – Month Jan 2020
● Trailblazer Programme commences – 3rd Feb 2020
Stage 2
● Amend programme based on findings from trailblazer programme – April 2020
● Early adopters invited – April 2020
● Progamme roll out – May 2020